机构:[1]State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, China.[2]Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.[3]Guangdong Keguanda Pharmaceutical Technology Co Ltd, Guangzhou, China.
This study was supported by the National Science
Foundation of Guangdong Province (2021A1515011062),
Guangdong Provincial Administration of Traditional Chinese
Medicine (20221211), Project of Zhanjiang City (2020B01346,
2021A05077), and Affiliated Hospital of Guangdong Medical
University (4SG21231G, LCYJ 2017A003, CLP202113001, and
LCYJ 2020B008).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|2 区医学
小类|2 区药学
最新[2025]版:
大类|3 区医学
小类|3 区药学
第一作者:
第一作者机构:[1]State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, China.[2]Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Huang Dan,Sun Chaoqun,Chen Min,et al.Bergenin ameliorates airway inflammation and remodeling in asthma by activating SIRT1 in macrophages to regulate the NF-κB pathway[J].Frontiers in pharmacology.2022,13:994878.doi:10.3389/fphar.2022.994878.
APA:
Huang Dan,Sun Chaoqun,Chen Min,Bai Shuyou,Zhao Xuanna...&Xu Youhua.(2022).Bergenin ameliorates airway inflammation and remodeling in asthma by activating SIRT1 in macrophages to regulate the NF-κB pathway.Frontiers in pharmacology,13,
MLA:
Huang Dan,et al."Bergenin ameliorates airway inflammation and remodeling in asthma by activating SIRT1 in macrophages to regulate the NF-κB pathway".Frontiers in pharmacology 13.(2022):994878